WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008103847) BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/103847    International Application No.:    PCT/US2008/054611
Publication Date: 28.08.2008 International Filing Date: 21.02.2008
IPC:
A61K 47/48 (2006.01)
Applicants: ALLACCEM, INCORPORATED [US/US]; Menlo Business Park, 1455 Adams Drive, Suite 1180, Menlo Park, California 94025 (US) (For All Designated States Except US).
WHITEFORD, Jeffery A. [US/US]; (US) (For US Only)
Inventors: WHITEFORD, Jeffery A.; (US)
Agent: MEYERTONS, HOOD, KIVLIN, KOWERT & GOETZEL, P.C.; MEYERTONS, Eric B., P.O. Box 398, Austin, Texas 78767-0398 (US)
Priority Data:
60/902,577 21.02.2007 US
60/964,312 10.08.2007 US
60/965,154 17.08.2007 US
61/029,332 16.02.2008 US
Title (EN) BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE
(FR) COMPOSITIONS À BASE DE COMPOSÉS POLYCYCLIQUES PONTÉS POUR L'INHIBITION ET LE TRAITEMENT DE MALADIES
Abstract: front page image
(EN)A pharmaceutically active agent, a pharmaceutically active agent carrier and method of use thereof are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at least two pharmaceutically active agents may be associated with the bridged polycyclic compound. In some embodiments, a bridged polycyclic compound may be pharmaceutically active. In some embodiments, a bridged polycyclic compound may be function as a carrier for pharmaceutically active agents.
(FR)L'invention concerne un agent pharmaceutiquement actif, un support d'agent pharmaceutiquement actif et une méthode d'utilisation de ces derniers. Dans certains modes de réalisation, un système peut comprendre une composition. La composition peut comprendre un ou plusieurs composés polycycliques pontés. Au moins un des composés polycycliques pontés peut comprendre au moins deux groupes cycliques, et au moins deux agents pharmaceutiquement actifs peuvent être associés au composé polycyclique ponté. Dans certains modes de réalisation, un composé polycyclique ponté peut être pharmaceutiquement actif. Dans certains modes de réalisation, un composé polycyclique ponté peut faire office de support d'agents pharmaceutiquement actifs.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)